Holdings of T. Rowe Price Health Sciences Portfolio
T. ROWE PRICE EQUITY SERIES, INC. · Original filing · Compare with another fund · Report an error
- Net assets
- 751.7M $ including 718.1M $ in equities, 95.5 %
- Positions
- 168 in 16 countries
- Bond lines
- 1 from 1 company
- Top ten
- 47.3 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 88,118 | 105.7M $ | 14.06 % |
| 2 | Johnson & Johnson | 196,487 | 49.9M $ | 6.64 % |
| 3 | UnitedHealth Group Inc | 106,378 | 44.2M $ | 5.88 % |
| 4 | AbbVie Inc | 153,028 | 38.5M $ | 5.12 % |
| 5 | Merck & Co Inc | 233,759 | 30M $ | 4.00 % |
| 6 | Gilead Sciences Inc | 166,271 | 21M $ | 2.79 % |
| 7 | Thermo Fisher Scientific Inc | 37,982 | 19M $ | 2.53 % |
| 8 | Vertex Pharmaceuticals Inc | 34,183 | 17M $ | 2.26 % |
| 9 | Bristol-Myers Squibb Co | 276,256 | 15.9M $ | 2.12 % |
| 10 | Abbott Laboratories | 158,573 | 14.4M $ | 1.91 % |
| 11 | Intuitive Surgical Inc | 35,632 | 14.2M $ | 1.89 % |
| 12 | Amgen Inc | 37,413 | 13.5M $ | 1.80 % |
| 13 | Stryker Corp | 42,615 | 13.4M $ | 1.78 % |
| 14 | Elevance Health Inc | 30,021 | 11.6M $ | 1.54 % |
| 15 | Danaher Corp | 56,740 | 10.8M $ | 1.44 % |
| 16 | NATERA INC | 39,765 | 10.8M $ | 1.44 % |
| 17 | GUARDANT HEALTH INC | 61,138 | 9.2M $ | 1.22 % |
| 18 | Cardinal Health Inc | 32,906 | 7.8M $ | 1.04 % |
| 19 | ROYALTY PHARMA PLC | 130,094 | 7.3M $ | 0.97 % |
| 20 | TENET HEALTHCARE CORP | 37,832 | 7.1M $ | 0.94 % |
| 21 | CVS Health Corp | 67,598 | 7M $ | 0.93 % |
| 22 | KYMERA THERAPEUTICS INC | 58,378 | 6.7M $ | 0.89 % |
| 23 | Protagonist Therapeutics Inc | 52,256 | 6.4M $ | 0.85 % |
| 24 | MODERNA INC | 89,300 | 6.3M $ | 0.83 % |
| 25 | REVOLUTION MEDICINES INC | 32,711 | 6.1M $ | 0.82 % |
| 26 | BRIGHTSPRING HEALTH SERVICES INC | 87,705 | 6.1M $ | 0.81 % |
| 27 | Roivant Sciences Ltd | 157,043 | 5.6M $ | 0.74 % |
| 28 | ALNYLAM PHARMACEUTICALS INC | 17,554 | 5.3M $ | 0.70 % |
| 29 | VIATRIS INC | 313,265 | 5M $ | 0.66 % |
| 30 | Charles River Laboratories International Inc | 20,331 | 4.6M $ | 0.61 % |
| 31 | Argenx SE | 4,836 | 4.5M $ | 0.60 % |
| 32 | Edwards Lifesciences Corp | 48,999 | 4.4M $ | 0.59 % |
| 33 | Centene Corp | 67,827 | 4.4M $ | 0.58 % |
| 34 | Spyre Therapeutics Inc | 47,651 | 4.2M $ | 0.56 % |
| 35 | Definium Therapeutics Inc | 81,159 | 3.8M $ | 0.51 % |
| 36 | Insmed Inc | 34,665 | 3.7M $ | 0.49 % |
| 37 | Chugai Pharmaceutical Co Ltd | 78,800 | 3.6M $ | 0.48 % |
| 38 | AstraZeneca PLC | 18,933 | 3.6M $ | 0.48 % |
| 39 | TWIST BIOSCIENCE CORP | 34,800 | 3.6M $ | 0.48 % |
| 40 | Boston Scientific Corp | 80,431 | 3.4M $ | 0.46 % |
| 41 | Medtronic PLC | 42,600 | 3.3M $ | 0.44 % |
| 42 | United Therapeutics Corp | 6,122 | 3.3M $ | 0.44 % |
| 43 | Krystal Biotech Inc | 8,820 | 3.3M $ | 0.44 % |
| 44 | Erasca Inc | 163,114 | 3M $ | 0.40 % |
| 45 | Billiontoone Inc | 24,722 | 3M $ | 0.39 % |
| 46 | Medpace Holdings Inc | 5,452 | 2.9M $ | 0.38 % |
| 47 | Ascendis Pharma A/S | 10,794 | 2.9M $ | 0.38 % |
| 48 | Praxis Precision Medicines Inc | 8,505 | 2.8M $ | 0.38 % |
| 49 | Scholar Rock Holding Corp | 51,768 | 2.8M $ | 0.38 % |
| 50 | BeOne Medicines Ltd | 130,452 | 2.8M $ | 0.38 % |
| 51 | Tango Therapeutics Inc | 88,611 | 2.8M $ | 0.37 % |
| 52 | ORUKA THERAPEUTICS INC | 28,926 | 2.8M $ | 0.37 % |
| 53 | Monte Rosa Therapeutics Inc | 112,745 | 2.7M $ | 0.36 % |
| 54 | Dianthus Therapeutics Inc | 27,805 | 2.7M $ | 0.36 % |
| 55 | Humana Inc | 6,700 | 2.7M $ | 0.35 % |
| 56 | Kodiak Sciences Inc | 64,006 | 2.5M $ | 0.33 % |
| 57 | Axsome Therapeutics Inc | 9,806 | 2.4M $ | 0.32 % |
| 58 | Relay Therapeutics Inc | 125,278 | 2.3M $ | 0.31 % |
| 59 | Summit Therapeutics Inc | 158,867 | 2.3M $ | 0.31 % |
| 60 | CG ONCOLOGY INC | 32,546 | 2.3M $ | 0.31 % |
| 61 | Novo Nordisk A/S | 47,201 | 2.3M $ | 0.30 % |
| 62 | CYTOKINETICS INC | 26,225 | 2.2M $ | 0.30 % |
| 63 | VERA THERAPEUTICS INC | 50,781 | 2.2M $ | 0.29 % |
| 64 | Regeneron Pharmaceuticals Inc | 3,492 | 2.2M $ | 0.29 % |
| 65 | IONIS PHARMACEUTICALS INC | 27,443 | 2.2M $ | 0.29 % |
| 66 | MBX BIOSCIENCES INC | 38,917 | 2.1M $ | 0.29 % |
| 67 | Agilent Technologies Inc | 15,700 | 2.1M $ | 0.28 % |
| 68 | Enliven Therapeutics Inc | 40,438 | 2.1M $ | 0.27 % |
| 69 | Crinetics Pharmaceuticals Inc | 53,507 | 2M $ | 0.27 % |
| 70 | MIRUM PHARMACEUTICALS INC | 17,030 | 2M $ | 0.27 % |
| 71 | Bridgebio Pharma Inc | 26,489 | 2M $ | 0.26 % |
| 72 | Madrigal Pharmaceuticals Inc | 3,670 | 2M $ | 0.26 % |
| 73 | NEWAMSTERDAM PHARMA COMPANY NV | 57,600 | 2M $ | 0.26 % |
| 74 | Waters Corp | 5,200 | 2M $ | 0.26 % |
| 75 | Nurix Therapeutics Inc | 79,238 | 1.9M $ | 0.26 % |
| 76 | Beam Therapeutics Inc | 55,798 | 1.9M $ | 0.25 % |
| 77 | Liquidia Corp | 22,754 | 1.8M $ | 0.24 % |
| 78 | Rhythm Pharmaceuticals Inc | 15,935 | 1.8M $ | 0.24 % |
| 79 | West Pharmaceutical Services Inc | 4,795 | 1.7M $ | 0.23 % |
| 80 | Ideaya Biosciences Inc | 45,571 | 1.7M $ | 0.23 % |
| 81 | Teva Pharmaceutical Industries Ltd | 49,500 | 1.7M $ | 0.22 % |
| 82 | VIRIDIAN THERAPEUTICS INC | 91,287 | 1.7M $ | 0.22 % |
| 83 | Alkermes PLC | 31,800 | 1.7M $ | 0.22 % |
| 84 | Immunome Inc | 78,194 | 1.7M $ | 0.22 % |
| 85 | ALIGNMENT HEALTHCARE INC | 69,056 | 1.6M $ | 0.22 % |
| 86 | Rapport Therapeutics Inc | 38,093 | 1.6M $ | 0.21 % |
| 87 | VAXCYTE INC | 26,234 | 1.5M $ | 0.20 % |
| 88 | PALVELLA THERAPEUTICS INC | 9,807 | 1.5M $ | 0.20 % |
| 89 | STRUCTURE THERAPEUTICS INC | 25,918 | 1.4M $ | 0.19 % |
| 90 | Immunocore Holdings PLC | 43,439 | 1.4M $ | 0.18 % |
| 91 | Climb Bio Inc | 102,500 | 1.3M $ | 0.18 % |
| 92 | ICON PLC | 7,500 | 1.3M $ | 0.17 % |
| 93 | Celldex Therapeutics Inc | 33,464 | 1.2M $ | 0.17 % |
| 94 | Kailera Therapeutics Inc | 55,664 | 1.2M $ | 0.16 % |
| 95 | Bicara Therapeutics Inc | 41,165 | 1.2M $ | 0.16 % |
| 96 | ORIC Pharmaceuticals Inc | 106,837 | 1.2M $ | 0.15 % |
| 97 | Encompass Health Corp | 10,970 | 1.1M $ | 0.15 % |
| 98 | MoonLake Immunotherapeutics | 55,515 | 1.1M $ | 0.14 % |
| 99 | Cencora Inc | 3,786 | 1.1M $ | 0.14 % |
| 100 | ALUMIS INC | 37,626 | 1.1M $ | 0.14 % |
The bonds it holds
This fund holds one bond line from 1 company. Only companies that already have a page on Titelia appear here.
| Rank | Company | Bond lines | Value | Weight |
|---|---|---|---|---|
| 1 | Immunocore Holdings PLC | 1 | 670.2K $ | 0.09 % |
Sector breakdown
- Health care 71.5 %
- Technology 0.1 %
- Unattributed 28.4 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 98.8 %
- JPY 0.5 %
- HKD 0.4 %
- CHF 0.1 %
- EUR 0.1 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 94.4 %
- Netherlands 1.0 %
- Bermuda 0.8 %
- Denmark 0.7 %
- United Kingdom 0.5 %
- Japan 0.5 %
- Ireland 0.4 %
- Hong Kong SAR China 0.4 %
- Cayman Islands 0.3 %
- France 0.3 %
- Israel 0.2 %
- Switzerland 0.1 %
- Other countries 0.3 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 144 | 678M $ | 94.41 % |
| 2 | Netherlands | 4 | 7.4M $ | 1.02 % |
| 3 | Bermuda | 1 | 5.6M $ | 0.77 % |
| 4 | Denmark | 2 | 5.1M $ | 0.72 % |
| 5 | United Kingdom | 2 | 3.9M $ | 0.54 % |
| 6 | Japan | 1 | 3.6M $ | 0.51 % |
| 7 | Ireland | 2 | 3M $ | 0.41 % |
| 8 | Hong Kong SAR China | 1 | 2.8M $ | 0.40 % |
| 9 | Cayman Islands | 2 | 1.9M $ | 0.27 % |
| 10 | France | 3 | 1.8M $ | 0.25 % |
| 11 | Israel | 1 | 1.7M $ | 0.23 % |
| 12 | Switzerland | 1 | 1M $ | 0.15 % |
Cite this page
Titelia. "Holdings of T. Rowe Price Health Sciences Portfolio". https://titelia.com/en/funds/S000002083